Insider Trading Alert - NATI, DXCM And CNC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 2, 2014, 70 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $290.00 to $8,010,680.00.

Highlighted Stocks Traded by Insiders:

National Instruments (NATI) - FREE Research Report

Davern Alexander M, who is Coo, Cfo & Executive Vp at National Instruments, sold 1,000 shares at $32.83 on Sept. 2, 2014. Following this transaction, the Coo, Cfo & Executive Vp owned 69,360 shares meaning that the stake was reduced by 1.42% with the 1,000-share transaction.

The shares most recently traded at $33.15, up $0.32, or 0.97% since the insider transaction. Historical insider transactions for National Instruments go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 8,173
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 16,173
  • 24-Week # shares bought: 5,500
  • 24-Week # shares sold: 32,091

The average volume for National Instruments has been 327,500 shares per day over the past 30 days. National Instruments has a market cap of $4.2 billion and is part of the technology sector and computer software & services industry. Shares are up 3.65% year-to-date as of the close of trading on Tuesday.

National Instruments Corporation designs, manufactures, and sells tools to engineers and scientists worldwide. The stock currently has a dividend yield of 1.81%. The company has a P/E ratio of 46.0. Currently, there is 1 analyst who rates National Instruments a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NATI - FREE

TheStreet Quant Ratings rates National Instruments as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full National Instruments Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

DexCom (DXCM) - FREE Research Report

Kahn Barbara, who is Director at DexCom, sold 4,000 shares at $44.52 on Sept. 2, 2014. Following this transaction, the Director owned 49,525 shares meaning that the stake was reduced by 7.47% with the 4,000-share transaction.

The shares most recently traded at $43.99, down $0.53, or 1.21% since the insider transaction. Historical insider transactions for DexCom go as follows:

  • 4-Week # shares sold: 23,803
  • 12-Week # shares sold: 27,303
  • 24-Week # shares sold: 54,045

The average volume for DexCom has been 711,200 shares per day over the past 30 days. DexCom has a market cap of $3.3 billion and is part of the health care sector and health services industry. Shares are up 26.57% year-to-date as of the close of trading on Tuesday.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. Currently, there are 9 analysts who rate DexCom a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DXCM - FREE

TheStreet Quant Ratings rates DexCom as a sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. Get the full DexCom Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Centene (CNC) - FREE Research Report

Imholz Donald G, who is EVP, Operations and CIO at Centene, sold 5,000 shares at $77.32 on Sept. 2, 2014. Following this transaction, the EVP, Operations and CIO owned 79,057 shares meaning that the stake was reduced by 5.95% with the 5,000-share transaction.

The shares most recently traded at $77.41, up $0.09, or 0.12% since the insider transaction. Historical insider transactions for Centene go as follows:

  • 4-Week # shares bought: 17,600
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 17,600
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 17,600
  • 24-Week # shares sold: 31,395

The average volume for Centene has been 819,700 shares per day over the past 30 days. Centene has a market cap of $4.6 billion and is part of the health care sector and health services industry. Shares are up 31.2% year-to-date as of the close of trading on Tuesday.

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Managed Care and Specialty Services. The company has a P/E ratio of 25.3. Currently, there are 8 analysts who rate Centene a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNC - FREE

TheStreet Quant Ratings rates Centene as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Centene Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home